-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Winbond Health evening of June 9 announcement, the company and Zhejiang Xinan Chemical Industrial Group Co.
, Ltd.
, Beijing Yingtai Jia and Biological Technology Co.
, Ltd.
signed a "strategic cooperation agreement"
.
In order to further promote the common development of the business, the parties are committed to the product layout and industrial chain in the fields of agrochemicals and genetic modification based on the principle of "complementary advantages, mutual support, mutual benefit and win-win" through friendly consultations.
Establish comprehensive and in-depth strategic partnerships in terms of expansion, market and channel coordination, and reach cooperation intentions
.
Winbond Health and its wholly-owned subsidiary, Zhuo Yuan Hui Medical Investment Co.
, Ltd.
, hold a total of 66.
76% of Yingtai Biotech
.
The company is the controlling shareholder of Yingtai Biological
The content of the cooperation shows that Winbon Health and Xin'an intend to use Yingtai Biotechnology as a cooperation platform, including but not limited to new agrochemical product development, GLP technical services, joint construction of technical service platforms, genetic modification and gene editing technology research, seed development, Cooperate in areas such as industrial chain layout, and cooperation methods include but are not limited to technical cooperation, business cooperation, etc.
; Xin'an shares and Yingtai Bio will combine their respective advantages and resources to strengthen cooperation in agrochemical product lines, etc.
, and joint ventures can be adopted to build factories.
, Deepen product supply chain cooperation, sales channel sharing and other methods to achieve product complementation and win-win cooperation; In order to better strengthen business cooperation in the agrochemical field, Winbond Health will choose the opportunity to take, including but not limited to, transfer its legal holdings to Xin'an.
some Yingtai biological equity, equity participation or consent Xin Ying Tai biological capital increase and other legal compliance, to support important biological Ying Tai Xin shares become shareholders
.
Winbond Health stated that the signing of the "Strategic Cooperation Agreement" will help the company's holding subsidiary Yingtai Biotechnology and Xin'an Co.
, Ltd.
to complement each other's advantages, and promote collaboration between the two parties in terms of technology research and development, production bases, market channels, and industrial chain management.
Further optimize the product and industrial layout, and enhance the core competitiveness of Yingtai Biotechnology
.
In the future, the company will choose the opportunity to transfer the equity of Yingtai Bio to Xin'an, and agree to Xin'an Share to participate in the capital increase and share expansion of Yingtai Bio, and support it to become an important shareholder of Yingtai Bio, which will help further reduce the company’s shareholding ratio in Yingtai Bio.
